| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | R07AX02 |
| UNII | 1Y740ILL1Z |
| EPA CompTox | DTXSID00236281 |
| InChI Key | PURKAOJPTOLRMP-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H28N2O3 |
| Molecular Weight | 392.5 |
| AlogP | 5.08 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 82.19 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 29.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Cystic fibrosis transmembrane conductance regulator positive modulator | POSITIVE MODULATOR | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Other ion channel
Chloride channel
Cystic fibrosis transmembrane conductance regulator
|
3-236 | - | - | - | - |
|
Protein: Cystic fibrosis transmembrane conductance regulator Description: Cystic fibrosis transmembrane conductance regulator Organism : Homo sapiens P13569 ENSG00000001626 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 66901 |
| ChEMBL | CHEMBL2010601 |
| DrugBank | DB08820 |
| DrugCentral | 4228 |
| FDA SRS | 1Y740ILL1Z |
| Human Metabolome Database | HMDB0015705 |
| Guide to Pharmacology | 4342 |
| PDB | VX7 |
| PharmGKB | PA165950341 |
| PubChem | 16220172 |
| SureChEMBL | SCHEMBL351373 |
| ZINC | ZINC000052509463 |